Rezultati pretraživanja
  1. prije 5 sati

    Required reading for the Passage Bio ( ) S-1: 's excellent profile on Wilson:

    2 korisnika označavaju da im se sviđa
  2. prije 10 sati

    Bought @ "Gann 4" [... front-running the market... but supported by fundamentals]. Looking OK... even in this adverse market.

  3. 3. velj

    Expecting huge recovery on oversold beaten down best in class and most promising Will only get higher from here if coronavirus stays relatively contained in US and outside China. and small plays in , data expected

    1 korisnik označava da mu se sviđa
  4. 2. velj

    Which is best trading strategy in for now?

    Which is best trading strategy in for now (week of 1/27/2020)?
    1 reply 1 korisnik označava da mu se sviđa
  5. 1. velj

    Regenxbio Earns “Buy” Rating from Chardan Capital

  6. 31. sij

    Regenxbio Stock Rating Reaffirmed by Chardan Capital

  7. 30. sij

    Here's a sneak peak of some of our Top Stock Picks for today. Start your free Barchart Premier trial to access the full list daily.

    1 korisnik označava da mu se sviđa
  8. 30. sij

    20 DMA Support today: ...

  9. 29. sij

    Biotech updates 01/29: discont HBV trial -22% offerings Orphan Drug Desig +13% Pipeline updates

    4 proslijeđena tweeta 6 korisnika označava da im se sviđa
  10. 29. sij

    Another one was that looked pennant like then broke back into pattern, currently a channel up

  11. 29. sij

    How much royalties will receive?

    1 reply 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  12. 29. sij

    3rd Qtr Royalties on $160M Sales ~ $9.2M 4th Qtr Royalties on $200M Sales ~ $13.6M (Estimated) 100 Patients/Qtr = $720M in 2020 sales - Royalties = $54M without any growth + $80M Milestone after 1st $1B in sales = ~ $134M (2020) not too shabby

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  13. 29. sij

    REGENXBIO Announces Presentations at the 16th Annual WORLDSymposium™ 2020

  14. 28. sij

    Top Gene-Sequencing Stocks for 2019

  15. 28. sij

    Steady increase in short interest continues reaching 11.9% of o/s shs as of Jan 15th for remaining tracking group now that and have been acquired.

    2 proslijeđena tweeta 6 korisnika označava da im se sviđa
  16. 28. sij

    has an average technical rating and it also does not offer a high quality setup at the moment.

  17. 28. sij

    Turn Green.. NOT Red... -2.57 %

  18. 28. sij

    12 big level. wet AMD is a big market. should get another update on its phase 1 trial short term. another one working on this indication.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  19. 27. sij

    20 DMA Support today: ...

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.